| Hypertension in end-stage renal disease: different measures and their prognostic significance. | |
| | |
MedLine Citation:
|
PMID: 20685828 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Hypertension is a risk factor for cardiovascular morbidity and mortality. Hypertension affects the majority of haemodialysis (HD) patients. However, in the absence of prospective data, accurate assessment of blood pressure (BP) and the level to which BP should be targeted remain still to be defined. A direct relationship between volume status and BP as well as between hypervolaemia and morbidity and mortality in HD patients indicates that normovolaemia is the key therapeutic target. Dry-weight reduction by additional ultrafiltration (even in the absence of clinical signs of volume overload) combined with daily dietary salt restriction or individually lowered dialysate sodium is recommended. Strict volume control allows marked reduction of antihypertensive drug treatment or makes it even unnecessary. Long, slow, home HD or frequent, short HD sessions or nocturnal HD also result in reduction of BP and left ventricular hypertrophy in end-stage renal disease patients. It will be interesting to see which recommendations will come from a conference sponsored by the Kidney Disease: Improving Global Outcomes on optimal BP treatment target in relation to end-organ damage and outcomes in HD patients, on antihypertensive drugs and on non-pharmacological therapies are to be considered in achieving BP targets in this population based on a paucity of prospective data. |
| | |
Authors:
|
Walter H Hörl |
Related Documents
:
|
3300758 - Some observations on the effects of a calcium channel blocker, nitrendipine, in early h... 9819018 - Prevalence, awareness, treatment and control of arterial hypertension in an elderly pop... 12420198 - Assessment of drug effects on blood pressure and pulse pressure using clinic, home and ... 15759028 - Nsaid use and bp in treated hypertensives: a retrospective controlled observational study. 17164828 - Effect of chronic coffee consumption on aortic stiffness and wave reflections in hypert... 11135078 - Real-time observation of hemodynamic changes in glomerular aneurysms induced by anti-th... |
Publication Detail:
|
Type: Journal Article; Review Date: 2010-08-04 |
Journal Detail:
|
Title: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association Volume: 25 ISSN: 1460-2385 ISO Abbreviation: Nephrol. Dial. Transplant. Publication Date: 2010 Oct |
Date Detail:
|
Created Date: 2010-09-23 Completed Date: 2011-01-13 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 8706402 Medline TA: Nephrol Dial Transplant Country: England |
Other Details:
|
Languages: eng Pagination: 3161-6 Citation Subset: IM |
Affiliation:
|
Division of Nephrology and Dialysis, Department of Medicine III, University of Vienna, Vienna, Austria. Walter.hoerl@meduniwien.ac.at |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Antihypertensive Agents
/
therapeutic use Blood Pressure Blood Volume Humans Hypertension / drug therapy*, physiopathology Kidney Failure, Chronic / physiopathology* Prognosis Renal Dialysis Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Cigarette smoking and second-hand smoking exposure in adolescents with chronic kidney disease: a stu...
Next Document: Sleep disorders, depressive symptoms and health-related quality of life--a cross-sectional compariso...